Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2008 Filed Mar 18, 2008 18:10 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 77 | $20.64 | $1,589.28 |
DisclosureSEC source: 0000078003-08-000044 · mac1694.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77 Underlying: Common Stock · 77 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 14, 2008 Filed Mar 18, 2008 18:10 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4,958 | $20.64 | $102,333.12 |
DisclosureSEC source: 0000078003-08-000045 · rea1696.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,533 Underlying: Common Stock · 4,958 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 14, 2008 Filed Mar 18, 2008 18:10 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 767 | $20.64 | $15,830.88 |
DisclosureSEC source: 0000078003-08-000046 · ric1697.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,799 Underlying: Common Stock · 767 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 06, 2008 Filed Mar 10, 2008 11:32 UTC |
SUSMAN SALLYSenior Vice President
|
PurchaseCommon Stock | 5,000 | $21.71 | $108,550.00 |
DisclosureSEC source: 0000078003-08-000037 · sus1687.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,462 Read SEC document |
| February 29, 2008 Filed Mar 4, 2008 01:04 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 40 | $22.28 | $891.20 |
DisclosureSEC source: 0000078003-08-000028 · kin1674.xml · derivative · entry 5 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,863 Underlying: Common Stock · 40 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| February 29, 2008 Filed Mar 4, 2008 17:22 UTC |
SUSMAN SALLYSenior Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $22.28 | $0.00 |
DisclosureSEC source: 0000078003-08-000035 · sus1686.xml · derivative · entry 2 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2018-02-28 Read SEC document |
| February 29, 2008 Filed Mar 4, 2008 17:22 UTC |
SUSMAN SALLYSenior Vice President
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000035 · sus1686.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,462 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 00:22 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 28,863 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000023 · bag1683.xml · derivative · entry 4 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,863 Underlying: Common Stock · 28,863 shares Expires 2013-02-28 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 00:22 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantCommon Stock | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000023 · bag1683.xml · nonDerivative · entry 2 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,877 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 00:22 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantCommon Stock | 7,133 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000023 · bag1683.xml · nonDerivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,777 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantStock Appreciation Rights · Derivative | 38,443 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000024 · can1684.xml · derivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,443 Underlying: Common Stock · 38,443 shares Expires 2013-02-28 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Tax withholdingCommon Stock | 1,530 | $22.55 | $34,501.50 |
DisclosureSEC source: 0000078003-08-000024 · can1684.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,887 Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000024 · can1684.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,417 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantCommon Stock | 9,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000024 · can1684.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,917 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantStock Appreciation Rights · Derivative | 168,739 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000025 · dam1675.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,739 Underlying: Common Stock · 168,739 shares Expires 2013-02-28 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantCommon Stock | 41,703 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000025 · dam1675.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,345 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 66,607 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000026 · fec1679.xml · derivative · entry 7 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,607 Underlying: Common Stock · 66,607 shares Expires 2013-02-28 F4 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F4 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
FECZKO JOSEPH MSenior Vice President
|
Tax withholdingCommon Stock | 2,306 | $22.55 | $52,000.30 |
DisclosureSEC source: 0000078003-08-000026 · fec1679.xml · nonDerivative · entry 3 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,749 Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantCommon Stock | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000026 · fec1679.xml · nonDerivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,055 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantCommon Stock | 16,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000026 · fec1679.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,955 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
GOODMAN COREY SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 97,691 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000027 · goo1678.xml · derivative · entry 3 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,691 Underlying: Common Stock · 97,691 shares Expires 2013-02-28 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
GOODMAN COREY SSenior Vice President
|
GrantCommon Stock | 24,144 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000027 · goo1678.xml · nonDerivative · entry 1 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,253 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantStock Appreciation Rights · Derivative | 399,645 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000028 · kin1674.xml · derivative · entry 6 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,645 Underlying: Common Stock · 399,645 shares Expires 2013-02-28 F4 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F4 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantCommon Stock | 98,771 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000028 · kin1674.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,596 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
MACKAY MARTINSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 159,858 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000029 · mac1676.xml · derivative · entry 5 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,858 Underlying: Common Stock · 159,858 shares Expires 2013-02-28 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
MACKAY MARTINSenior Vice President
|
Tax withholdingCommon Stock | 1,604 | $22.55 | $36,170.20 |
DisclosureSEC source: 0000078003-08-000029 · mac1676.xml · nonDerivative · entry 3 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,531 Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 5,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000029 · mac1676.xml · nonDerivative · entry 2 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,135 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 39,508 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000029 · mac1676.xml · nonDerivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,035 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
MCLEOD MARY SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 88,810 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000030 · mcl1682.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,810 Underlying: Common Stock · 88,810 shares Expires 2013-02-28 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
MCLEOD MARY SSenior Vice President
|
GrantCommon Stock | 21,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000030 · mcl1682.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,018 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
READ IAN CSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 168,739 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000031 · rea1677.xml · derivative · entry 5 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,739 Underlying: Common Stock · 168,739 shares Expires 2013-02-28 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
READ IAN CSenior Vice President
|
Tax withholdingCommon Stock | 2,359 | $22.55 | $53,195.45 |
DisclosureSEC source: 0000078003-08-000031 · rea1677.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,309 Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 7,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000031 · rea1677.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,668 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 41,703 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000031 · rea1677.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,568 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 77,709 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000032 · ric1680.xml · derivative · entry 5 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,709 Underlying: Common Stock · 77,709 shares Expires 2013-02-28 F3 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F3 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
RICCIARDI NATALE SSenior Vice President
|
Tax withholdingCommon Stock | 1,614 | $22.55 | $36,395.70 |
DisclosureSEC source: 0000078003-08-000032 · ric1680.xml · nonDerivative · entry 3 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,819 Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000032 · ric1680.xml · nonDerivative · entry 2 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,433 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 19,205 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000032 · ric1680.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,593 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:05 UTC |
SUSMAN SALLYSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 66,607 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000033 · sus1681.xml · derivative · entry 2 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,607 Underlying: Common Stock · 66,607 shares Expires 2013-02-28 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:05 UTC |
SUSMAN SALLYSenior Vice President
|
GrantCommon Stock | 16,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000033 · sus1681.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,462 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:05 UTC |
WAXMAN ALLEN PSenior Vice President
|
Tax withholdingCommon Stock | 1,099 | $22.55 | $24,782.45 |
DisclosureSEC source: 0000078003-08-000034 · wax1685.xml · nonDerivative · entry 2 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,341 Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:05 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantCommon Stock | 3,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000034 · wax1685.xml · nonDerivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,440 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 22, 2008 Filed Feb 26, 2008 19:23 UTC |
WAXMAN ALLEN PSenior Vice President
|
Tax withholdingCommon Stock | 3,814 | $22.50 | $85,815.00 |
DisclosureSEC source: 0000078003-08-000022 · wax1673.xml · nonDerivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,190 Read SEC document |
| January 31, 2008 Filed Feb 4, 2008 13:35 UTC |
STEERE WILLIAM C JRDirector
|
Tax withholdingCommon Stock | 47,886 | $23.36 | $1,118,616.96 |
DisclosureSEC source: 0000078003-08-000015 · ste1671.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,577,999 Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:42 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 1,467 | $22.73 | $33,344.91 |
DisclosureSEC source: 0000078003-08-000001 · cor1668.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,840 Underlying: Common Stock · 1,467 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:42 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 888 | $22.73 | $20,184.24 |
DisclosureSEC source: 0000078003-08-000002 · kil1667.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,888 Underlying: Common Stock · 888 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:43 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 1,379 | $22.73 | $31,344.67 |
DisclosureSEC source: 0000078003-08-000004 · ste1666.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,989 Underlying: Common Stock · 1,379 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:43 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 2,011 | $22.73 | $45,710.03 |
DisclosureSEC source: 0000078003-08-000003 · mea1669.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,381 Underlying: Common Stock · 2,011 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 49 | $22.73 | $1,113.77 |
DisclosureSEC source: 0000078003-08-000006 · can1659.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 43 | $22.73 | $977.39 |
DisclosureSEC source: 0000078003-08-000005 · bag1658.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,944 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.